Literature DB >> 22689057

Molecular basis for the tissue specificity of β-catenin oncogenesis.

A Sharma1, J M Sen.   

Abstract

Wnt-β-catenin-T-cell factor signaling is causally linked to c-myc-dependent tumorigenesis in mouse and human colon epithelial cells. By contrast, β-catenin is not similarly associated with oncogenic transformation of other tissues, including T cells. The molecular basis for tissue specificity of β-catenin-dependent oncogenesis is unknown. Here, we demonstrate that adenomatous polyposis coli mutant APC(Min/+) mice, which have increased expression of β-catenin in all tissues, develop severe intestinal neoplasia, but fail to develop thymic lymphoma. Whereas β-catenin-dependent signals elicit a proliferative response from intestinal cells, thymocytes experience oncogene-induced senescence (OIS), growth arrest and apoptosis. We demonstrate that the differential cellular response of thymocytes and intestinal epithelial cells is a direct consequence of the gene expression elicited by β-catenin expression in each tissue. We find that whereas intestinal cells induce genes that promote proliferation thymocytes induce expression of genes associated with OIS, growth arrest and p53-dependent apoptosis. We correlate gene expression pattern with the role β-catenin plays in the development of each tissue and suggest that susceptibility of transformation by β-catenin is intimately related to its function during development. We propose that when oncogenes are used as signaling molecules, safety nets in the form of OIS, growth arrest and apoptosis prevent accidental transformation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689057      PMCID: PMC3534820          DOI: 10.1038/onc.2012.215

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  54 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Somatic activation of beta-catenin bypasses pre-TCR signaling and TCR selection in thymocyte development.

Authors:  F Gounari; I Aifantis; K Khazaie; S Hoeflinger; N Harada; M M Taketo; H von Boehmer
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

3.  Deletion of beta-catenin impairs T cell development.

Authors:  Youyuan Xu; Daliya Banerjee; Joerg Huelsken; Walter Birchmeier; Jyoti Misra Sen
Journal:  Nat Immunol       Date:  2003-11-09       Impact factor: 25.606

4.  The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.

Authors:  Marc van de Wetering; Elena Sancho; Cornelis Verweij; Wim de Lau; Irma Oving; Adam Hurlstone; Karin van der Horn; Eduard Batlle; Damien Coudreuse; Anna Pavlina Haramis; Menno Tjon-Pon-Fong; Petra Moerer; Maaike van den Born; Gwen Soete; Steven Pals; Martin Eilers; Rene Medema; Hans Clevers
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

5.  Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.

Authors:  David M Dorfman; Harvey A Greisman; Aliakbar Shahsafaei
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

6.  Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.

Authors:  A Damalas; S Kahan; M Shtutman; A Ben-Ze'ev; M Oren
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

7.  Beta-catenin expression in thymocytes accelerates thymic involution.

Authors:  Youyuan Xu; Jyoti Sen
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

8.  Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice.

Authors:  Anne-Maria Pajari; Johanna Rajakangas; Essi Päivärinta; Veli-Matti Kosma; Joseph Rafter; Marja Mutanen
Journal:  Int J Cancer       Date:  2003-09-20       Impact factor: 7.396

9.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

Authors:  A R Moser; H C Pitot; W F Dove
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

10.  Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin.

Authors:  Eun Joo Chung; Sang-Gu Hwang; PhuongMai Nguyen; Sunmin Lee; Jung-Sik Kim; Jin Woo Kim; Pierre A Henkart; Donald P Bottaro; Lilian Soon; Paolo Bonvini; Su-Jae Lee; Judith E Karp; Ho Jung Oh; Jeffrey S Rubin; Jane B Trepel
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

View more
  10 in total

1.  A critical role for the regulated wnt-myc pathway in naive T cell survival.

Authors:  Chunshu Wong; Chong Chen; Qi Wu; Yang Liu; Pan Zheng
Journal:  J Immunol       Date:  2014-11-26       Impact factor: 5.422

Review 2.  From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells.

Authors:  Farrah C Steinke; Hai-Hui Xue
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

3.  The expression of tumour suppressors and proto-oncogenes in tissues susceptible to their hereditary cancers.

Authors:  Brian Muir; Leonard Nunney
Journal:  Br J Cancer       Date:  2015-06-16       Impact factor: 7.640

4.  MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer.

Authors:  Muzafar A Macha; Asif Khurshid Qazi; Seema Chugh; Moorthy P Ponnusamy; Priya Pai; Satyanarayana Rachagani; Punita Dhawan; Yuri M Sheinin; Kavita Mallya; Ramesh Pothuraju; Surinder K Batra
Journal:  Genes Cancer       Date:  2016-05

5.  The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.

Authors:  Daniela Kovacs; Emilia Migliano; Luca Muscardin; Vitaliano Silipo; Caterina Catricalà; Mauro Picardo; Barbara Bellei
Journal:  Oncotarget       Date:  2016-07-12

6.  CTNNB1 Knockdown Inhibits Cell Proliferation and Aldosterone Secretion Through Inhibiting Wnt/β-Catenin Signaling in H295R Cells.

Authors:  Tingting Zhou; Pengwei Luo; Liang Wang; Shiwei Yang; Shiyuan Qin; Zhitao Wei; Jiwen Liu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

7.  The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas.

Authors:  Machteld M Tiemessen; Miranda R M Baert; Tom Schonewille; Martijn H Brugman; Farbod Famili; Daniela C F Salvatori; Jules P P Meijerink; Ugur Ozbek; Hans Clevers; Jacques J M van Dongen; Frank J T Staal
Journal:  PLoS Biol       Date:  2012-11-20       Impact factor: 8.029

8.  Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing.

Authors:  Jeremy D K Parker; Yaoqing Shen; Erin Pleasance; Yvonne Li; Jacqueline E Schein; Yongjun Zhao; Richard Moore; Joanna Wegrzyn-Woltosz; Kerry J Savage; Andrew P Weng; Randy D Gascoyne; Steven Jones; Marco Marra; Janessa Laskin; Aly Karsan
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-03

9.  Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.

Authors:  Tobias Sinnberg; Mitchell P Levesque; Jelena Krochmann; Phil F Cheng; Kristian Ikenberg; Francisco Meraz-Torres; Heike Niessner; Claus Garbe; Christian Busch
Journal:  Mol Cancer       Date:  2018-02-17       Impact factor: 27.401

10.  Non-target genetic manipulation induces rhabdomyosarcoma in KrasPten-driven mouse model of ovarian cancer.

Authors:  Huiling Lai; Yunyun Guo; Weipeng He; Tingting Sun; Linglong Ouyang; Liming Tian; Yuanyuan Li; Xiaohui Li; Zeshan You; Guofen Yang
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.